Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant

Today, more than 80% of patients with Hodgkin lymphoma (HL) can be cured with first-line treatment [1–3]. For patients with HL suffering from relapse or progression after first-line therapy, high d...